Utopia, dystopia: Separating truth from fiction in bioethics discussions
05 June 2015
Let’s face it: Imagining the means of humanity’s ultimate destruction makes for great entertainment. There are no shortages of novels, movies and television shows featuring threats of global annihilation – zombie viruses, meteors hurtling through space, nuclear warfare – or opening up post-apocalyptic landscapes laid waste following a collision of unchecked scientific and technologic advances with the those worst of human traits – greed, irresponsibility, megalomania.
Cancer in the crosshairs: ASCO brings fresh ideas, data jubilee across types
05 June 2015
No one was surprised to see immune-based therapies taking much of the air time at this year's American Society of Clinical Oncology (ASCO) meeting, since they've dominated the key scientific powwow in cancer for several years, and a fountain of outcomes showed that targeted drugs, in combination regimens as well as single agents, still have plenty going for them.
China’s registration fees for drugs, devices seeing a drastic rise
05 June 2015
Biotech and medtech companies operating in China now have to pay more attention to the cost of regulatory approvals after the national regulator drastically raised registration application fees for both clinical trials and marketing approvals.
Getting better all the time for drug, medical device safety in China?
04 June 2015
Over the weekend, China's leadership took the time to focus again on ensuring the quality of consumer goods with an underlying message for the medical device and drug industries highlighted by recent probes of top officials.
Big Pharma grapples with idiosyncrasies of orphan drug marketing
04 June 2015
Orphan drugs are not alone anymore. Booming interest in R&D for drugs to treat rare diseases resulted in a record 440+ requests submitted to the FDA last year, with almost 300 designations granted and 48 approved--both also records. Then there are the M&A deals fueled by orphan meds, as major drugmakers snap up smaller drug developers to gain a foothold in the field.
NovaMedica To Market Ferring’s IBD Therapies in Russia
04 June 2015
The Russian pharmaceutical company NovaMedica and the Swiss biopharmaceutical company Ferring Pharmaceuticals have established a partnership to bring novel gastroenterological drug treatments for inflammatory bowel disease (IBD) to Russia. The two companies announced the signing of an agreement for commercializing a product line of treatments for ulcerative colitis, Crohn’s disease and bleeding fromesophageal varicose.
Artificial intelligence tops Google VC's list of high-potential life sci techs
04 June 2015
Google Ventures President Bill Maris has put artificial intelligence at the top of a list of 8 technologies he sees as having the potential to revolutionize life sciences. The technologies are part of what Maris calls life science's "transistor moment," a trigger that will enable healthcare to advance at a rate comparable to the rapid rise of computing in recent decades.
Look for orphan drugs to keep fueling M&A, Moody's says
03 June 2015
Orphan drugs are attractive to make thanks to premium pricing prospects, limited competition and regulatory perks. But those factors also make them attractive to buy, and they'll continue to spur M&A activity in the biopharma field, Moody's predicts.
New Chart Pack: Big Strides in Fight Against Cancer
03 June 2015
In December 2009, Matt Ellefson received news from his doctor that no one ever wants to receive: a diagnosis of advanced non-small cell lung cancer. He faced a five-year survival rate of less than five percent. Nearly six years later, Matt is not only surviving, but thriving, thanks in part to innovations in cancer medicines.
High Prices for Drugs Attacked at Meeting
03 June 2015
In a sign of growing frustration with rising drug prices, a prominent cancer specialist on Sunday sharply criticized the costs of new cancer treatments in a high-profile speech at one of the largest annual medical meetings in the U.S.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024